New answers tagged

0

I agree with @mpprogram6771 and @iayork. Development of ELISA kits consumes more time to develop and validate - the first on the market last year were not recommendable. Now a variety of immunoglobuin SARS-CoV-2 ELISA kits are available. Mainly using IgG or IgM - IgM to detect early signs of infection, IgG for long term response. Eg: here


Top 50 recent answers are included